{"ticker":"ARWR","companyName":"ARROWHEAD PHARMACEUTICALS, INC.","fiscalYear":2025,"executiveName":"Christopher Anzalone","executiveTitle":"President and Chief Executive Officer","totalComp":9029861,"salary":981046,"stockAwards":6810292,"nonEquityIncentive":1236000,"otherComp":2523,"yoyChangePct":-27.32165804466656,"source":{"filingType":"DEF 14A","filingDate":"2026-01-27","filingUrl":"https://www.sec.gov/Archives/edgar/data/879407/000087940726000019/arwr-20260126.htm"},"lastUpdated":"2026-04-05T09:57:34.173Z"}